Cargando…
Identification of chemoresistance‐related mRNAs based on gemcitabine‐resistant pancreatic cancer cell lines
Gemcitabine (GEM) alone and GEM‐based chemotherapy are the preferred regimens for treating advanced unresectable and metastatic pancreatic cancer (PC). However, these treatments have limited efficacy due to acquired resistance of cancer cells to chemotherapy, the mechanisms of which are not fully un...
Autores principales: | Zhou, Jiarong, Zhang, Linshi, Zheng, Huilin, Ge, Wenhao, Huang, Yu, Yan, Yingcai, Zhou, Xiaohu, Zhu, Wei, Kong, Yang, Ding, Yuan, Wang, Weilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997050/ https://www.ncbi.nlm.nih.gov/pubmed/31823522 http://dx.doi.org/10.1002/cam4.2764 |
Ejemplares similares
-
GSK343 induces autophagy and downregulates the AKT/mTOR signaling pathway in pancreatic cancer cells
por: Xu, Hao, et al.
Publicado: (2019) -
RRAD suppresses the Warburg effect by downregulating ACTG1 in hepatocellular carcinoma
por: Yan, Yingcai, et al.
Publicado: (2019) -
Automatic Detection and Classification of Focal Liver Lesions Based on Deep Convolutional Neural Networks: A Preliminary Study
por: Zhou, Jiarong, et al.
Publicado: (2021) -
Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?
por: Luo, Wenhao, et al.
Publicado: (2019) -
Differentially expressed lncRNAs and mRNAs identified by NGS analysis in colorectal cancer patients
por: Li, Meng, et al.
Publicado: (2018)